Meeting to be held in Chicago on January 23 and in the Midwest on January 24 hosted by Piper Sandler.Invest with Confidence: Follow TipRanks' ...

Chicago, IL – January 24, 2025 – Today, Zacks Equity Research Equity are Enovis ENOV, Omnicell OMCL and Phreesia PHR. Link: ...

Phreesia (PHR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

Analyst predicts Phreesia's revenue per client will accelerate, as company shifts focus to monetizing existing clients. Upgraded rating and PT raised.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $31.0, a high estimate of $34.00, and a low estimate of $29.00. This upward trend is apparent, ...

Phreesia (PHR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Phreesia (NYSE:PHR – Free Report) had its price objective raised by Citigroup from $31.00 to $35.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have a buy ...

In a report released today, Jailendra Singh from Truist Financial assigned a Buy rating to Phreesia (PHR – Research Report). The company’s ...

Phreesia stock opened at $27.12 on Thursday. The company’s 50-day moving average price is $23.18 and its 200-day moving average price is $22.71. The company has a quick ratio of 1.77, a current ...

Phreesia, Inc. (NYSE:PHR), a leading healthcare technology company specializing in patient intake management and workflow optimization, has been garnering attention from analysts and investors alike.